Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

QIAstat-Dx BCID GPF Plus AMR Panel

K-Number: K254194 · 2026-08-06

ApplicantQIAGEN GmbH
Decision Date2026-08-06
Product CodePAM
Advisory CommitteeMI
DecisionSubstantially Equivalent

Device Summary

QIAstat-Dx BCID GPF Plus AMR Panel is the device name listed in this FDA 510(k) record. The listed applicant is QIAGEN GmbH. It received FDA 510(k) clearance on 2026-08-06 under 510(k) number K254194. The device is classified under product code PAM. It was reviewed by the MI advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the QIAstat-Dx BCID GPF Plus AMR Panel?

QIAstat-Dx BCID GPF Plus AMR Panel is a medical device that received FDA 510(k) clearance on 2026-08-06. The listed applicant is QIAGEN GmbH. The 510(k) number is K254194.

When did QIAstat-Dx BCID GPF Plus AMR Panel receive FDA 510(k) clearance?

QIAstat-Dx BCID GPF Plus AMR Panel received FDA 510(k) clearance on 2026-08-06, under 510(k) number K254194.

Who is the listed applicant for QIAstat-Dx BCID GPF Plus AMR Panel?

The FDA 510(k) record lists QIAGEN GmbH as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for QIAstat-Dx BCID GPF Plus AMR Panel?

The FDA product code for QIAstat-Dx BCID GPF Plus AMR Panel is PAM.

Other records listing QIAGEN GmbH as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

View all 22 devices →

Related Devices (Code: PAM)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.